Allosteric Modulation of the Cannabinoid CB1 Receptor

Operational models of pharmacological agonism

J.W. Black, P. Leff · Proceedings of the Royal Society of London. Series B, Biological sciences · 1983 · 1.1K citations

Medicine, Pharmacology, General Pharmacology +16

Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

Frederick J. Ehlert · Molecular Pharmacology · 1988 · 355 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Aymen I. Idris, Rob vanʼt Hof, Iain R. Greig et al. · Nature Medicine · 2005 · 351 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding

Stephane Litschig, F. Gasparini, D Rueegg et al. · Molecular Pharmacology · 1999 · 343 citations

Life Sciences, Neuroscience, Pharmacology +16

The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry Inhibitor

Christian Watson, Stephen Jenkinson, Wieslaw M. Kazmierski et al. · Molecular Pharmacology · 2005 · 302 citations

Medicine, Medicinal Chemistry, Pharmacology +16